drugset / Trial / NCT00823173
Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether ESBA105, a topically applied TNF-alpha inhibitor, is safe and clinically active when applied to the eye of patients suffering from acute anterior uveitis
Timeline
- Start
- 2009-01
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ESBA105 | Monoclonal antibody | 10 mg/ml | Topical |